PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression

Dai Horiuchi(Northwestern University), Roman Camarda(University of California, San Francisco), Alicia Y. Zhou(University of California, San Francisco), Christina Yau(Buck Institute for Research on Aging), Olga Momčilović(University of California, San Francisco), Sanjeev Balakrishnan(University of California, San Francisco), Alexandra Corella(University of California, San Francisco), Henok Eyob(University of California, San Francisco), Kai Kessenbrock(University of California, San Francisco), Devon A. Lawson(University of California, San Francisco), Lindsey A. Marsh(Northwestern University), Brittany Anderton(University of California, San Francisco), Julia Rohrberg(University of California, San Francisco), Ratika Kunder(Northwestern University), Alexey V. Bazarov(Lawrence Berkeley National Laboratory), Paul Yaswen(Lawrence Berkeley National Laboratory), Michael T. McManus(University of California, San Francisco), Hope S. Rugo(University of California, San Francisco), Zena Werb(UCSF Helen Diller Family Comprehensive Cancer Center), Andrei Goga(UCSF Helen Diller Family Comprehensive Cancer Center)
Nature Medicine
October 24, 2016
Cited by 167

Abstract


Related Papers

No related papers found

Powered by citation graph analysis